|
1
|
Hardingham T: Extracellular matrix and
pathogenic mechanisms in osteoarthritis. Curr Rheumatol Rep.
10:30–36. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lorenzo P, Bayliss MT and Heinegård D:
Altered patterns and synthesis of extracellular matrix
macromolecules in early osteoarthritis. Matrix Biol. 23:381–391.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suzuki M, Hashizume M, Yoshida H, Shiina M
and Mihara M: IL-6 and IL-1 synergistically enhanced the production
of MMPs from synovial cells by up-regulating IL-6 production and
IL-1 receptor I expression. Cytokine. 51:178–183. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Martel-Pelletier J, Boileau C, Pelletier
JP and Roughley PJ: Cartilage in normal and osteoarthritis
conditions. Best Pract Res Clin Rheumatol. 22:351–384. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Billinghurst RC, Wu W, Ionescu M, et al:
Comparison of the degradation of type II collagen and proteoglycan
in nasal and articular cartilages induced by interleukin-1 and the
selective inhibition of type II collagen cleavage by collagenase.
Arthritis Rheum. 43:664–672. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yasuda T and Poole AR: A fibronectin
fragment induces type II collagen degradation by collagenase
through an interleukin-1-mediated pathway. Arthritis Rheum.
46:138–148. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wheaton AJ, Borthakur A, Shapiro EM, et
al: Proteoglycan loss in human knee cartilage: quantitation with
sodium MR imaging - feasibility study. Radiology. 231:900–905.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gabay C, Lamacchia C and Palmer G: IL-1
pathways in inflammation and human diseases. Nat Rev Rheumatol.
6:232–241. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gouze E, Pawliuk R, Gouze JN, et al:
Lentiviral-mediated gene delivery to synovium: potent
intra-articular expression with amplification by inflammation. Mol
Ther. 7:460–466. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Morisset S, Frisbie DD, Robbins PD, Nixon
AJ and McIlwraith CW: IL-1ra/IGF-1 gene therapy modulates repair of
microfractured chondral defects. Clin Orthop Relat Res.
462:221–228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen B, Qin J, Wang H, Magdalou J and Chen
L: Effects of adenovirus-mediated bFGF, IL-1Ra and IGF-1 gene
transfer on human osteoarthritic chondrocytes and osteoarthritis in
rabbits. Exp Mol Med. 42:684–695. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sobol M, Bartkowiak A, de Haan B and de
Vos P: Cytotoxicity study of novel water-soluble chitosan
derivatives applied as membrane material of alginate microcapsules.
J Biomed Mater Res A. 101:1907–1914. 2013. View Article : Google Scholar
|
|
13
|
Lih E, Lee JS, Park KM and Park KD:
Rapidly curable chitosan-PEG hydrogels as tissue adhesives for
hemostasis and wound healing. Acta Biomater. 8:3261–3269. 2012.
View Article : Google Scholar
|
|
14
|
Chang SH, Hsiao YW and Lin HY:
Low-frequency electromagnetic field exposure accelerates
chondrocytic phenotype expression on chitosan substrate.
Orthopedics. 34:202011.
|
|
15
|
Haupt JL, Frisbie DD, McIlwraith CW, et
al: Dual transduction of insulin-like growth factor-I and
interleukin-1 receptor antagonist protein controls cartilage
degradation in an osteoarthritic culture model. J Orthop Res.
23:118–126. 2005. View Article : Google Scholar
|
|
16
|
Lee JE, Kim KE, Kwon IC, et al: Effects of
the controlled-released TGF-beta1 from chitosan microspheres on
chondrocytes cultured in a collagen/chitosan/glycosaminoglycan
scaffold. Biomaterials. 25:4163–4173. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu H, Wang S, Fang H, et al:
Chitosan-polycaprolactone copolymer microspheres for transforming
growth factor-β1 delivery. Colloids Surf B Biointerfaces. 82:602–8.
2011.PubMed/NCBI
|
|
18
|
Zhao J, Fan X, Zhang Q, et al:
Chitosan-plasmid DNA nanoparticles encoding small hairpin RNA
targeting MMP-3 and -13 to inhibit the expression of
dedifferentiation related genes in expanded chondrocytes. J Biomed
Mater Res A. 102:373–380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Suh JK and Matthew HW: Application of
chitosan-based polysaccharide biomaterials in cartilage tissue
engineering: a review. Biomaterials. 21:2589–2598. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zeng W, Huang J, Hu X, et al: Ionically
cross-linked chitosan microspheres for controlled release of
bioactive nerve growth factor. Int J Pharm. 421:283–290. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Simonaro CM: Cartilage and chondrocyte
pathology in the mucopolysaccharidoses: The role of
glycosaminoglycan-mediated inflammation. J Pediatr Rehabil Med.
3:85–88. 2010.PubMed/NCBI
|
|
22
|
Jacques C, Gosset M, Berebaum F and Gabay
C: The role of IL-1 and IL-1Ra in joint inflammation and cartilage
degradation. Vitam Horm. 74:371–403. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baragi VM, Renkiewicz RR, Jordan H, et al:
Transplantation of transduced chondrocytes protects articular
cartilage from interleukin 1-induced extracellular matrix
degradation. J Clin Invest. 96:2454–2460. 1995. View Article : Google Scholar
|
|
24
|
Aida Y, Maeno M, Suzuki N, et al: The
effect of IL-1beta on the expression of inflammatory cytokines and
their receptors in human chondrocytes. Life Sci. 79:764–771. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pattani A, Patravale VB, Panicker L and
Potdar PD: Immunological effects and membrane interactions of
chitosan nanoparticles. Mol Pharm. 6:345–352. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song S, Zhou F, Nordquist RE, et al:
Glycated chitosan as a new non-toxic immunological stimulant.
Immunopharmacol Immunotoxicol. 31:202–208. 2009. View Article : Google Scholar : PubMed/NCBI
|
